Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-01-23FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved Genentech's supplemental application for Cellcept (mycophenolate mofetil), under NDA 050722, confirming a change/update via…
-
FDA approval · 2014-01-08FDA Approved: MYCOPHENOLIC ACID — Original Application (Archis Pharma LLC)
FDA approved Archis Pharma LLC's original application for mycophenolic acid, granting approval of a generic version for use in preventing or…
-
FDA approval · 2014-01-08FDA Approved: SIROLIMUS — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves an original generic application for sirolimus from Zydus Pharmaceuticals USA Inc., establishing a generic version of the immuno…
-
FDA approval · 2013-09-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech.
-
FDA approval · 2013-09-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz Inc's mycophenolate mofetil.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-09-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for MYCOPHENOLATE MOFETIL by Accord Healthcare Inc., marking an update to its regulatory status rela…
-
FDA approval · 2013-09-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Mycophenolate mofetil from Strides Pharma Science Limited under the ANDA program. This action au…
-
FDA approval · 2013-07-24FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved Genentech's supplemental application for CELLCEPT (mycophenolate mofetil), indicating an approved modification related to i…
-
FDA approval · 2013-05-07FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
FDA approved Sandoz's supplemental application for tacrolimus, making a generic tacrolimus product available for preventing organ transplant…
-
FDA approval · 2013-04-08FDA Approved: NULOJIX — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for NULOJIX (belatacept) submitted by E.R. Squibb & Sons, L.L.C., marking an additional regulato…
-
FDA approval · 2013-02-14FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) from Genentech, Inc.
-
FDA approval · 2013-02-14FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CellCept (mycophenolate mofetil) submitted by Genentech, Inc., updating the labeling to refl…
-
FDA approval · 2013-02-07FDA Approved: SANDIMMUNE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for SANDIMMUNE (cyclosporine) from Novartis, indicating updated labeling or expanded use via a suppl…
-
FDA approval · 2012-10-12FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for tacrolimus submitted by Sandoz Inc.
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for mycophenolate mofetil from Sandoz Inc, authorizing changes to the product as part of the sup…
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for mycophenolate mofetil submitted by Mylan Pharmaceuticals Inc. The action updates the product's l…
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Mycophenolate mofetil from Strides Pharma Science Limited, enabling the generic product to b…
-
FDA approval · 2012-09-10FDA Approved: TACROLIMUS — Supplemental Application (Accord Healthcare Inc.)
FDA approves a supplemental application for tacrolimus from Accord Healthcare Inc., resulting in updated labeling and/or indications for the…
-
FDA approval · 2012-07-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., resulting in changes to the approved …
-
FDA approval · 2012-07-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., indicating a modification to an a…
-
FDA approval · 2012-06-28FDA Approved: TACROLIMUS — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for tacrolimus (generic) to update the product, which is used to prevent orga…
-
FDA approval · 2012-06-27FDA Approved: TACROLIMUS — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for tacrolimus submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2011-11-28FDA Approved: TACROLIMUS — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for tacrolimus from Quallent Pharmaceuticals Health LLC to support continued marketing of the im…
-
FDA approval · 2011-11-18FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for tacrolimus submitted by Sandoz Inc. (ANDA065461), authorizing a tacrolimus product as part of th…
-
FDA approval · 2011-11-04FDA Approved: TACROLIMUS — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for tacrolimus submitted by Padagis Israel Pharmaceuticals Ltd.